Article
Helper-dependent adenoviral gene therapy mediates long-term correction of the clotting defect in the canine hemophilia A model.
Journal of thrombosis and haemostasis : JTH - 1 Jun 2006
McCORMACK W M, Seiler M P, Bertin T K, Ubhayakar K, Palmer D J, Ng P, Nichols T C, Lee B
Abstract excerpt
BACKGROUND: Adenoviral vector-mediated gene therapy might have potential for long-term correction of the monogenic disease hemophilia A. OBJECTIVE: In this study, we tested the efficacy of administering a helper-dependent adenoviral vector (HDV) designed for maximal liver-restricted canine factor VIII (cFVIII) expression on three out-bred hemophilia A dogs. METHODS: Three FVIII-deficient animals from the...
Topics
- Adenoviridae
- Animals
- Blood Coagulation
- Disease Models, Animal
- Dogs
- Factor VIII
- Genetic Therapy
- Genetic Vectors
- Hemophilia A
- Liver
- Mutation
